Multidrug resistance in Escherichia coli has become a worrying issue that is increasingly
observed in human but also in veterinary medicine worldwide. E. coli is intrinsically …

Antibiotic resistance has become a global public health priority. Polymyxins, a family of
cationic polypeptide antibiotics, act as a final line of refuge against severe infections by …

The role of food‐producing environments in the emergence and spread of antimicrobial
resistance (AMR) in EU plant‐based food production, terrestrial animals (poultry, cattle and …

Background and aim Plasmid-mediated colistin resistance mechanisms have been
identified worldwide in the past years. A multiplex polymerase chain reaction (PCR) protocol …

Polymyxins are important lipopeptide antibiotics that serve as the last-line defense against
multidrug-resistant (MDR) Gram-negative bacterial infections. Worryingly, the clinical utility …

Colistin is considered to be an antimicrobial of last-resort for the treatment of multidrug-
resistant Gram-negative bacterial infections. The recent global dissemination of mobilized …

Global emergence of Gram-negative bacteria carrying the plasmid-borne resistance genes,
bla MBL and mcr, raises a significant challenge to the treatment of life-threatening infections …

Background: Antimicrobial resistance is a serious public-health problem throughout the
world. Escherichia coli, the most common Gram-negative microorganism, has developed …

Colistin, also known as polymyxin E, is an antimicrobial agent that is effective against a
variety of Gram-negative bacilli, especially the Enterobacteriaceae family. Recently, the wide …

Escherichia coli is the most common Gram-negative bacterial pathogen, presenting both a
clinical and an epidemiological challenge. In the last decade, several successful multidrug …